Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Baylor College of Medicine, Berry Genomics Co. Seek to Improve on Prenatal Genetic Tests

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
Teams aim to improve prenatal genetic testing by combining BCM’s expertise in using microarrays for DNA analysis and Berry’s non-invasive technology evaluating fetal DNA in maternal plasma.

BCM’s highly ranked genetics program, led by National Academy of Sciences member Dr. Arthur Beaudet, has been dedicated to providing the medical community with high-quality and comprehensive genetics testing services for over 30 years. BCM’s Medical Genetics Lab has pioneered the development and use of microarray technology for the testing of prenatal/pediatric genetic disorders for more than 50,000 cases.

The microarray testing uses a gene-chip to assess the make-up of chromosomes (organized structures of DNA and proteins that are found in cells) in a particular part of the human genome (genetic blue print). In areas of the genome, there are portions of the genetic material that show imbalances because they are duplicated or deleted abnormally with gains and losses of genetic information that may signal risk for a genetic disorder.

Berry Genomics has developed technologies to screen and test for genetic abnormalities of the fetus by evaluating fetal DNA in maternal plasma. This technology avoids invasive prenatal diagnostic procedures of chorionic villus sampling, which requires samples being taken from the placenta, and/or amniocentesis, where samples are taken from the amniotic sac around the developing fetus.

These procedures have been a source of anxiety and apprehension for expectant mothers, Beaudet said.

"We are committed to improving the diagnostic sensitivity of invasive prenatal testing as exemplified by our participation in a recently published collaborative National Institutes of Health-funded study," said Dr. Arthur Beaudet, chair and professor of molecular and human genetics at BCM. "We are conducting research to enable non-invasive prenatal testing to detect all the conditions currently detected by invasive testing. It is an honor and a privilege to participate in this international collaboration."

"We are very pleased to enter this agreement with Baylor College of Medicine," said Dr. Daixing Zhou, CEO of Berry Genomics. "Non-invasive prenatal testing and microarray technology are rapidly changing the way we detect genetic diseases. By collaborating with Baylor College of Medicine, we are now able to offer the complete solutions for prenatal screening and diagnosis."

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Antibodies Block Norovirus’ Entrance into Cells
Scientists have uncovered a mechanism in the human body that targets and successfully blocks noroviruses.
Tuesday, September 20, 2016
Growing Noroviruses in the Lab
Human noroviruses – the leading viral cause of acute diarrhea around the world – have been difficult to study because scientists had not found a way to grow them in the lab.
Tuesday, August 30, 2016
Neurodvelopmental Disorder Cause Linked to SON Gene
A genetic link has been discovered for a previously unxplained neurodevelopmental disorder.
Tuesday, August 23, 2016
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Friday, May 20, 2016
Largest Genomic Study on Kidney Cancer
Understanding the complexity of cancer is a major goal of the scientific community, and for kidney cancer researchers this goal just got closer.
Wednesday, March 16, 2016
Largest Genomic Study on Kidney Cancer Brings Hope for More Effective Treatments
Researchers at Baylor College of Medicine have found that a pathway called immune checkpoint was most active in a subtype of clear cell kidney cancer that is typically very aggressive.
Tuesday, March 08, 2016
Baylor, DNAnexus Collaborate
Partnership sets out to develop HgV, a new iteration of HGSC's Mercury, a BCM-developed data processing and variant calling pipeline for analyzing and annotating next-generation sequencing data in research and clinical contexts.
Tuesday, June 23, 2015
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Tuesday, May 26, 2015
Role of Cancer Stem Cells in Chemo-Resistance
'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancer.
Friday, December 05, 2014
Massimo Pietropaolo Named McNair Scholar at Baylor
World renowned physician-scientist in type 1 diabetes research, Dr. Massimo Pietropaolo, has been named McNair Scholar at Baylor College of Medicine.
Wednesday, October 29, 2014
Clinical Integration of NGS
Experts provide much-needed policy analysis for clinical integration of next generation sequencing.
Tuesday, September 23, 2014
Collaboration Unravels Novel Mechanism for Neurological Disorder
The novel gene (CLP1) associated with a neurological disorder affecting both the peripheral and central nervous systems.
Saturday, April 26, 2014
$3M NIH Grant Enables Baylor International HIV/AIDS Program
Researchers to study genetic differences of disease in sub-Saharan African children.
Wednesday, February 19, 2014
Microarray Analysis Improves Prenatal Diagnosis
A "chip" or array that can quickly detect disorders such as Down syndrome, or other diseases associated with chromosomal abnormalities, has proved an effective tool in prenatal diagnosis in 300 cases, as reported by Baylor College of Medicine.
Tuesday, November 29, 2011
Experimental Drug Targets Chemo-Resistant Breast Cancer Stem Cells
The cells that remain after treatment that could potentially refuel tumor growth, researchers say.
Monday, December 14, 2009
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
A Simple Tool for Clinical and Postmortem Toxicological Analysis
In this study, GC-MS is used for the determination of clozapine, and five antidepressants in human plasma, serum and whole blood.
Identification of Individual Red Blood Cells by Raman Microspectroscopy
In this study, Raman Microspectroscopy was used to identify individual red blood cells.
Fighting Cancer with the Power of Immunity
Researchers at MIT have used a combination of four different therapies to activate both of the immune system’s two branches, producing a coordinated attack that led to the complete disappearance of large, aggressive tumors in mice.
NIH Researchers Unveil New Wound-Healing Role for Protein-Folding Gene in Mice
The study found that topical treatment of an Hsp60-containing gel dramatically accelerates wound closure in a diabetic mouse model.
50-Year-Old Bacteria Could Be Alternative Treatment Option for Cancer
Researchers have developed a non-toxic strain of Salmonella to penetrate and target cancer cells.
Promising Blood Test Fails to Yield Clues About Best Strategies for Bladder Cancer Treatment
Penn Medicine research challenges previous findings on utility of neutrophil-to-lymphocyte ratio as a biomarker.
Robotic Cleaning Technique Could Automate Neuroscience Research
New robotic cleaning technique allows pipettes used in patch-clamping to be re-used up to 11 or more times.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos